Hyphens Pharma International Ltd banner

Wall St Price Targets

1J5 Price Forecast
Based on 3 analysts

+27% Upside
from S$0.345 today

Hyphens Pharma International Ltd (1J5)’s 12-month stock price forecast through November 2027 has a consensus target of S$0.439, implying 27% upside. The forecast is based on price targets from 3 Wall Street analysts.

1J5 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 1J5 yet.

Hyphens Pharma International Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1J5's stock price target?
Price Target
0.439 SGD

According to Wall Street analysts, the average 1-year price target for 1J5 is 0.439 SGD with a low forecast of 0.404 SGD and a high forecast of 0.483 SGD.

What is the Revenue forecast for Hyphens Pharma International Ltd?
Projected CAGR
3%

Over the last 9 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 3%.

What is the Gross Profit forecast for Hyphens Pharma International Ltd?
Projected CAGR
5%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for Hyphens Pharma International Ltd?
Projected CAGR
3%

Over the last 9 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 2 years is 3%.

What is the Pre-Tax Income forecast for Hyphens Pharma International Ltd?
Projected CAGR
44%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 2 years is 44%.

What is the Net Income forecast for Hyphens Pharma International Ltd?
Projected CAGR
29%

Over the last 9 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 29%.

Back to Top